MODERNA cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

Cases of RSV across the country are considered "very high," as rates of other acute respiratory illnesses are also high, the CDC reported Monday.

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

However, more acute respiratory illnesses like influenza, COVID & respiratory syncytial virus (RSV) are on the rise. News 10 ...

The US Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information for the Abrysvo (Pfizer) and Arexvy (GlaxoSmithKline) respiratory syncytial ...

Chances are someone in your life has been sick over the past couple of weeks as respiratory illnesses, like the flu and ...

Most U.S. states are reporting high or very high flu-like activity, while COVID-19 rates remain lower than this time last year.

Six states reported "very high" levels of respiratory illness activity: Arizona, Oklahoma, Kentucky, New Hampshire, Delaware and Hawaii. Here are five more updates from the CDC report: Emergency ...

When broken down by state, most of the country is experiencing elevated respiratory illness, including a few states with ...

Two Greenville-area hospital systems will begin restricting patient visitations due to increased flu and respiratory illnesses.

In the Lehigh Valley, cases of the flu and RSV are particularly prevalent compared with many other parts of the state.

Moderna cut its 2025 sales forecast by $1 billion today, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending its shares down more than ...